If you decide that ‘unapproved’ medicinal cannabis products are clinically appropriate for your patient, there are four access pathways:
- Authorised Prescriber – Established History of Use pathway
- Authorised Prescriber – Standard pathway
- SAS Category A notification pathway
- SAS Category B application pathway